The Canadian venture capital firm's sophomore fund, which aims to target $125 million, recently completed a first close of $58 million. This funding round received support from several investors, including Ceniarth, the Equality Fund, KfW, the Skoll Foundation, and Wire Group. The focus of this investment is on women’s and children’s health.

The convergence of investment capital around women's and children's health signals a growing recognition of this sector's systemic importance, moving it from niche advocacy to mainstream financial consideration among institutional investors. The involvement of organizations like the Skoll Foundation and KfW alongside private funds suggests that the focus on this area is supported by both philanthropic goals and broader economic development objectives. This pattern suggests that framing health priorities as investment opportunities creates leverage for capital allocation. The lack of explicit detail regarding Cross-Border's specific strategy leaves open questions about how the stated focus translates into tangible impact across the cross-border landscape, and who ultimately bears the responsibility for ensuring this capital drives equitable outcomes rather than reinforcing existing structures. What mechanisms are in place to ensure that the interests of women and children are the primary drivers of investment decisions, rather than merely thematic overlays? How do these diverse funders align their mandates to achieve integrated, measurable health equity goals across different jurisdictions?